The View Alum Jedediah Bila Has a Surprising Response to Rumors of Show Drama
breeds drama: producers can't control hosts, manage conflict or control leaking. My take on the show is that working atbrings out the worst in people.
I believe that all the women and the staff are working under conditions where the culture is so f--ked up, it feels like quicksand."has been a platform on air and behind the scenes for strong women. Live television and different perspectives can often lead to surprising moments, but the team is collaborative and supportive—focused on delivering an informative daily talk show to our loyal viewers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Analysis: What drives Sinema? A different view of politicsAnalysis: Democrats can't pass the 'Build Back Better' agenda in spite of the Arizona senator. They have to work with her.
Read more »
A 'deeply humiliated and heartbroken' Meghan McCain decided to leave 'The View' after this on-air spat'I just wanted to share and hopefully make people feel a little less alone': Meghan McCain shares personal stories in the new audio book 'Bad Republican.'
Read more »
'SNL': Jason Sudeikis' 2012 Joe Biden Returns for Epic Cold OpenJason Sudeikis' smiling, shades-wearing 2012 Joe Biden time travels to the modern day in SNL's latest memorable 'Cold Open' sketch.
Read more »
Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11Interim results of a Phase 2/3 trial showed Moderna's Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday.
Read more »
Megan Thee Stallion's Entourage Has Awkward Headbutt with Martin BrundleMeg's team wasn't having it, but Brundle was having even less.
Read more »
Moderna Data Shows Covid-19 Vaccine Produced Strong Immune Response in 6- to 11-Year-OldsModerna said it would submit the results from an interim study to health regulators in the U.S., Europe and elsewhere in seeking authorization for 6- to 11-year-olds.
Read more »